Yeah, you are so right..... 6/19 Volume 23.6 Million shares 6/18 volume 25.7 Million shares 6/15 volume 25.9 Million shares 6/14 volume 34.3 Million shares 6/13 volume 137.7 Million shares 6/12 volume 26.6 Million shares
what's that saying about buying a "falling knife"? Is there an opposite one for shorting a rocket?
4% dividend, nice growth, $12B tax free stock buyback. Seriously, why wouldn't someone buy? It's not a get rich quick stock, but if you need a consumer and/or drug stock in your portfolio, this is a great way to get that exposure
I believe that all the falling knives have already dropped. With the Synthes acquisition now complete, and the host of new drugs and medical devices from J&J, the stock could even break through the $70 barrier which has stood for so long.